T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Veralto
VLTO
|
+$1.39B |
| 2 |
Lattice Semiconductor
LSCC
|
+$366M |
| 3 |
Canadian Natural Resources
CNQ
|
+$329M |
| 4 |
TechnipFMC
FTI
|
+$306M |
| 5 |
Tyler Technologies
TYL
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$1.05B |
| 2 |
Texas Instruments
TXN
|
+$639M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$473M |
| 4 |
Equifax
EFX
|
+$465M |
| 5 |
TransUnion
TRU
|
+$408M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.08% |
| 2 | Healthcare | 20.34% |
| 3 | Industrials | 12.93% |
| 4 | Consumer Discretionary | 12.56% |
| 5 | Financials | 12.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRSH
101
Marsh
MRSH
$90.1B
| $446M | 0.29% |
2,355,885
-292,139
| -11% | -$56.5M |
|
102
KLA
KLAC
$272B
| $446M | 0.29% |
7,676,770
-5,083,600
| -40% | -$265M |
|
103
West Pharmaceutical
WST
$24.8B
| $438M | 0.29% |
1,244,800
-381,064
| -23% | -$135M |
|
104
PennyMac Financial
PFSI
$4B
| $434M | 0.28% |
4,912,601
+75,954
| +2% | +$5.7M |
|
105
Element Solutions
ESI
$9.37B
| $418M | 0.27% |
18,054,603
+369,580
| +2% | +$7.46M |
|
106
Liberty Media Series C
FWONK
$26B
| $403M | 0.26% |
6,389,461
+108,376
| +2% | +$7.09M |
|
|
CCC
107
CCC Intelligent Solutions
CCC
$4.11B
| $402M | 0.26% |
35,296,322
+3,856,182
| +12% | +$45M |
|
108
Raymond James Financial
RJF
$34.9B
| $395M | 0.26% |
3,544,623
-5,615
| -0.2% | -$578K |
|
109
Mobileye
MBLY
$7.48B
| $387M | 0.25% |
8,928,746
+818,416
| +10% | +$32.2M |
|
110
Pinnacle Financial Partners Inc
PNFP
$16.1B
| $381M | 0.25% |
4,366,639
+103,991
| +2% | +$7.54M |
|
|
SEE
111
DELISTED
Sealed Air
SEE
| $379M | 0.25% |
10,373,797
+254,760
| +3% | +$8.35M |
|
112
Littelfuse
LFUS
$11.7B
| $379M | 0.25% |
1,415,163
-66,772
| -5% | -$16M |
|
|
APLS
113
DELISTED
Apellis Pharmaceuticals
APLS
| $377M | 0.25% |
6,303,584
-215,887
| -3% | -$11M |
|
114
Enovis
ENOV
$1.42B
| $369M | 0.24% |
6,582,110
+8,042
| +0.1% | +$401K |
|
115
IDEX
IEX
$17.7B
| $368M | 0.24% |
1,693,253
+19,191
| +1% | +$3.87M |
|
116
EastGroup Properties
EGP
$10.9B
| $367M | 0.24% |
2,000,631
+11,302
| +0.6% | +$1.93M |
|
117
Ulta Beauty
ULTA
$22.9B
| $360M | 0.23% |
735,661
+226,415
| +44% | +$95.5M |
|
118
MarketAxess Holdings
MKTX
$5.72B
| $360M | 0.23% |
1,228,330
-28,443
| -2% | -$6.88M |
|
119
Bright Horizons
BFAM
$3.76B
| $355M | 0.23% |
3,765,243
-708,268
| -16% | -$60.4M |
|
120
Verisk Analytics
VRSK
$23.5B
| $349M | 0.23% |
1,462,654
-669,697
| -31% | -$159M |
|
121
FirstService
FSV
$6.24B
| $347M | 0.23% |
2,138,477
-339,612
| -14% | -$51.3M |
|
122
SouthState Bank Corp
SSB
$10.7B
| $333M | 0.22% |
3,939,491
+24,856
| +0.6% | +$1.83M |
|
123
RPM International
RPM
$14.7B
| $331M | 0.22% |
2,962,270
-919,664
| -24% | -$92.9M |
|
124
Fortinet
FTNT
$118B
| $329M | 0.21% |
5,613,538
-1,292,007
| -19% | -$71.4M |
|
125
AXIS Capital
AXS
$7.26B
| $328M | 0.21% |
5,928,188
-969,707
| -14% | -$53.9M |
|
Similar funds
T. Rowe Price Investment Management's Q4 2023 Portfolio in Review
As of Q4 2023, T. Rowe Price Investment Management held 644 positions worth $154B, up 8.7% from $141B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Investment Management's Q4 2023 filing shows 73 new, 297 increased, 219 reduced and 48 closed positions. Its largest new stake was Veralto: 18,675,505 shares worth $1.54B. The largest sale was Thermo Fisher Scientific, an estimated $1.05B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.
- T. Rowe Price Investment Management's largest Q4 2023 buy was Veralto: 18,675,505 shares worth $1.54B.
- T. Rowe Price Investment Management added most to Lattice Semiconductor in Q4 2023, an estimated $366M increase.
- T. Rowe Price Investment Management's biggest Q4 2023 reduction was Thermo Fisher Scientific, cutting an estimated $1.05B.
- T. Rowe Price Investment Management fully exited Texas Instruments in Q4 2023, selling an estimated $639M.
- T. Rowe Price Investment Management's ten largest holdings make up 16% of its $154B portfolio in Q4 2023.
- T. Rowe Price Investment Management opened 73 new positions and closed 48 in Q4 2023.
- T. Rowe Price Investment Management's portfolio value rose 8.7% quarter-over-quarter to $154B.
Based on T. Rowe Price Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.